Advancing Human Longevity
Zenth Health Sciences is the Aevum Zenth conglomerate's dedicated arm for life sciences, pharmaceutical R&D, and next-generation medical infrastructure, serving 140 million patients annually across 62 countries.
Core Pillars of Operation
Pharmaceuticals
End-to-end drug discovery utilizing AI-driven molecular modeling and high-throughput screening. Focus areas include oncology, neurodegenerative disorders, and infectious diseases.
MedTech & Devices
Design and manufacture of minimally invasive surgical tools, implantable sensors, and diagnostic imaging systems powered by Zenth Digital's AI algorithms.
Hospital Network
Ownership and operation of 1,200+ medical facilities worldwide. Integration of standardized care protocols and Aevum Logistics for supply chain resilience.
Innovation Pipeline
| Project Name | Category | Description | Phase | Status |
|---|---|---|---|---|
| Project Aesculapius | Gene Therapy | CRISPR-based treatment for Cystic Fibrosis | Phase 3 | Clinical III |
| Nano-Bio Delivery | Drug Delivery | Targeted nanoparticle delivery for glioblastoma | Phase 2 | Clinical II |
| NeuralLink Z | Neurotech | Non-invasive BCI for stroke rehabilitation | Phase 1 | Clinical I |
| VaxShield-9 | Vaccines | Universal flu vaccine platform | Approved | Approved |
| CardioPatch | MedTech | Bio-resorbable stent with drug elution | Phase 3 | Clinical III |
Global Presence
Zenth Health Sciences operates a tiered network of facilities ensuring access to world-class care across all continents. Our facilities are integrated with Aevum Energy for carbon-neutral operations.
North America
450 Facilities, 12 Research Centers
Europe & EMEA
380 Facilities, 8 Research Centers
Asia Pacific
320 Facilities, 5 Research Centers
Latin America & Africa
50 Facilities, 2 Research Centers